Atossa Therapeutics Investor Presentation May 2024

Atossa Therapeutics presents clinical development updates for (Z)-endoxifen in breast density and breast cancer indications. The presentation covers regulatory pathways, clinical trial progress, and financial guidance for the biopharmaceutical company.